Join to View Full Profile
300 Pasteur DrStanford, CA 94305
Phone+1 650-723-4000
Dr. Subramanian is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins UniversityFellowship, Infectious Disease, 1997 - 2000
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 1994 - 1997
University of Michigan Medical SchoolClass of 1994
Certifications & Licensure
CA State Medical License 2013 - 2027
MD State Medical License 1997 - 2013
OH State Medical License 1996 - 1998
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Publications & Presentations
PubMed
- Solid Organ Transplantation Among Transplant Candidates With TB Disease.Cybele Lara R Abad, Alex Zimmet, Aruna K Subramanian
Clinical Transplantation. 2026-04-01 - Comparing Efficacy and Safety of Itraconazole Solution Versus Posaconazole for Antifungal Prophylaxis After Heart Transplant.Ralph Tayyar, Darra Drucker, Roy Lee, Thu Le, Jeff Teuteberg
Open Forum Infectious Diseases. 2026-04-01 - Strategies to Mitigate Infection Risk in Patients Receiving Complement Inhibitor Therapy.Aruna K Subramanian, Anuja Java, Samir K Gupta, Shailesh Gupta, Andrew S Bomback
Clinical Infectious Diseases. 2026-02-18
Journal Articles
- Impact of Pre-Transplant Donor BK Viruria in Kidney Transplant RecipientsAruna K Subramanian, Amy E Gallo, Jane C Tan, Gregory A Storch, Jason Kurzer, Benjamin A Pinsky, Waldo Concepcion, Susanna K Tan, Diane Alonso, The Journal of Infectious Diseases
Other
- Remdesivir for 5 or 10 Days in Patients with Severe Covid-19Aruna Subramanian, MD, The New England Journal of Medicine
https://www.doximity.com/articles/5d801831-c3b0-4ab4-9bf0-19bd673040b5
UpToDate, Wolters Kluwer Health - 2011-06-15
Authored Content
- Remdesivir for 5 or 10 Days in Patients with Severe Covid-19May 2020
- Remdesivir for 5 or 10 Days in Patients with Severe Covid-19May 2020
Press Mentions
What Does COVID-19 Do to Your Brain?February 7th, 2022- Antibodies in Blood Soon After COVID-19 Onset May Predict SeverityJanuary 18th, 2022
- Promising COVID Treatments Could Reach San Francisco Pharmacies by JanuaryDecember 3rd, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
